Corient IA LLC

Position in NVO — Novo Nordisk A S

CIK 2058426 MIAMI, FL

Position in NVO

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$83,895

-$86,257 QoQ

Shares Held

1,750

-62.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#1,082

of 1,348 holders

Holding Since

Mar 2025

6 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Corient IA LLC holds $3,212,123 across 7 Drug Manufacturers - General names. NVO ranks #7 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,670	$2,003,048
2	GILD	Gilead Sciences, Inc.	3,540	$447,243
3	AMGN	Amgen Inc	890	$322,286
4	NVS	Novartis AG	1,030	$161,421
5	GSK	GSK plc	1,980	$103,791
6	SNY	Sanofi	2,120	$90,439
7	NVO	Novo Nordisk A S This page	1,750	$83,895

6 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$83,895	1,750	-62.2%	Shares	Sole	2026-08-12
2026-03-31	$170,152	4,630	0.0%	Shares	Sole	2026-05-14
2025-12-31	$235,574	4,630	-33.9%	Shares	Sole	2026-02-13
2025-09-30	$388,430	7,000	-16.7%	Shares	Sole	2025-11-12
2025-06-30	$579,768	8,400	0.0%	Shares	Sole	2025-08-14
2025-03-31	$583,296	8,400	—	Shares	Sole	2025-05-13
No filing history on record for this holder in this stock.